Filing Flows › Lifecore Biomedical (LFCR) › R&D spending
Lifecore Biomedical (LFCR) R&D spending by quarter
Lifecore Biomedical's R&D spending was $1.4M in Q1 FY27 (first quarter fiscal 2027), -8% from Q1 FY27. Over the last 6 quarters it ranged from $1.2M (Q3 FY26) to $2.0M (Q3 FY25).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $1.4M | -8% | -28% |
| Q1 FY27 | $1.5M | +26% | -22% |
| Q3 FY26 | $1.2M | -38% | -40% |
| Q1 FY26 | $2.0M | -4% | — |
| Q3 FY25 | $2.0M | +6% | — |
| Q2 FY25 | $1.9M | — | — |
Q1 FY27 at a glance
Lifecore Biomedical, Q1 FY27: revenue $25.3M (-19% year over year), operating margin -3.5%, net loss $40.1M, operating cash flow $6.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Lifecore Biomedical's R&D spending?
Lifecore Biomedical's R&D spending was $1.4M in Q1 FY27 (first quarter fiscal 2027), -8% from Q1 FY27.
How has Lifecore Biomedical's R&D spending changed?
Over the last 6 quarters it ranged from $1.2M (Q3 FY26) to $2.0M (Q3 FY25).